Global Health Q2 results: net profit rises 39.3% to Rs 220.67 crore
Global Health Limited, which runs Medanta hospitals, reported consolidated Q2 FY27 revenue of Rs 1,469.04 crore and net profit of Rs 220.67 crore in a filing with the National Stock Exchange.
Key points
- Global Health Limited reported consolidated Q2 FY27 net profit of Rs 220.67 crore, up 39.3% from a year earlier and 39.0% from the previous quarter.
- Its consolidated revenue from operations was Rs 1,469.04 crore, up 33.6% year on year and 12.7% quarter on quarter, the filing shows.
- The board also approved a project budget of Rs 997 crore for a 500-bed hospital at Ghaziabad in Uttar Pradesh, the company said in the filing.
Global Health Limited, the company behind the Medanta hospitals, reported a consolidated net profit of Rs 220.67 crore for the second quarter of FY27, the quarter ended 30 September 2026. Its revenue from operations was Rs 1,469.04 crore. The company disclosed the unaudited results in a filing with the National Stock Exchange on 3 November 2026.
What Happened
The company's board approved the unaudited standalone and consolidated results for the quarter and the half year ended 30 September 2026 at a meeting on 3 November 2026. The figures below are consolidated, in which the company combines its subsidiaries with its own accounts.
Revenue from operations was Rs 1,469.04 crore. That is 33.6% higher than the Rs 1,099.28 crore in the same quarter a year earlier (YoY) and 12.7% higher than the Rs 1,304.05 crore in the previous quarter (QoQ).
Net profit attributable to the owners of the company was Rs 220.67 crore. That is 39.3% higher than Rs 158.44 crore a year earlier and 39.0% higher than Rs 158.73 crore in the previous quarter. Basic earnings per share were Rs 8.21, against Rs 5.89 a year earlier and Rs 5.91 in the previous quarter.
For the half year ended 30 September 2026, revenue from operations was Rs 2,773.09 crore, against Rs 2,130.12 crore a year earlier. Net profit attributable to the owners was Rs 379.40 crore, against Rs 317.45 crore. The half-year figure for the earlier year included exceptional items, which the filing's notes describe.
The statutory auditors, Walker Chandiok & Co LLP, issued a limited review report with an unmodified opinion on the results, the company said.
In the same filing, the company said its board approved a project budget of Rs 997 crore, including the cost of land, to build a 500-bed hospital at Siddharth Vihar Yojna in Ghaziabad, Uttar Pradesh. The land parcel of 10,560.36 square metres was allotted by the UP Housing and Development Board.
What It Means
The filing gives readers a direct record of how the hospital operator's income and profit moved over the quarter, the previous quarter and the same quarter last year. These are unaudited figures that were reviewed, not audited, by the statutory auditors.
The company's figures, not any estimate, are the basis for the changes reported here. The filing does not forecast future results. The proposed Ghaziabad hospital is a budget approval; the filing does not say when the hospital will open.
Shareholders and others who want the full statements, the notes and the balance sheet can read the company's filing with the National Stock Exchange, which is linked with this report. Complaints against listed companies can be lodged at https://scores.sebi.gov.in.
Oquilia Data: Global Health Ltd. (NSE: MEDANTA)
| Close, 2 Nov 2026 | Rs 1,298.40 (+2.21% on the day) |
|---|---|
| Return 1M / 3M / 6M / YTD / 1Y | −4.34% / −7.63% / +16.21% / +9.44% / −1.00% |
| Against Nifty 50, 1M / 3M / YTD | −8.88 / −3.76 / +19.73 points |
| 52-week closing high / low | Rs 1,508.90 (27 Aug 2026) / Rs 961.10 (30 Mar 2026) |
| Turnover, 20-session average | Rs 26.59 cr; 59.9% delivered; latest volume 1.3x |
Closes adjusted for splits and bonuses; returns exclude dividends. Facts from NSE's files, not investment advice.
Full record: Global Health share price on Oquilia
Source: Company filing on NSE
Sources & Citations
- Company filing on NSE — National Stock Exchange of India